European Journal of Pharmacology 1997: Vol 333 Index

11 Pages·1997·2 MB·English

co
European Journal of Pharmacology 333 (1997) 293-295
Author index
Abe, Y., see Inamura, N. (333) 79 Diaz, A., Mayet, S. and Dickenson, A.H.
Abiko, Y., see Chen, M. (333) 261 BU-224 produces spinal antinociception as an agonist at imidazoline
Ahmad, S. I, receptors (333) 9
Angiotensin receptor antagonists delay nitric oxide-deficient stroke in Dickenson, A.H., see Diaz, A. (333) 9
stroke-prone rats (333) 39 Doak, GJ., see Sawynok, J. (333) |
Anton, F., see Cortijo, J. (333) 69 D’Orléans-Juste, P., see Berthiaume, N. (333) 55
Aoba, A., see Miyamoto, S. (333) 279 Duridanova, D.B., Gagov, H.S. and Boev, K.K.
Araki, T., see Ishizaki, K. (333) 207 Two populations of smooth muscle cells in the guinea-pig gastric
Asai, T., see Matsushima, S. (333) 93 antrum (333) 105
Asaka, T., see Inoue, H. (333) 231
Asakura, M., see Miyamoto, S. (333) 279 Ebert, B., Mikkelsen, S., Thorkildsen, C. and Borgbjerg, F.M.
Asano, M., see Inamura, N. (333) 79 Norketamine, the main metabolite of ketamine, is a non-competitive
Aslan, N., Gren, Z., Onat, F. and Oktay, §. NMDA receptor antagonist in the rat cortex and spinal cord (333) 99
Carbachol-induced pressor responses and muscarinic M, receptors in Eto, T., see Khan, A.1. (333) 187
the central nucleus of amygdala in conscious rats (333) 63
Aura, J., Sirvié, J. and Riekkinen Jr., P. Fournier, A., see Pheng, L.H. (333) R3
Methoctramine moderately improves memory but pirenzepine disrupts Fu, M.L.X., see Skomedal, T. (333) 169
performance in delayed non-matching to position test (333) 129 Fujita, H., see Kageyama, M. (333) 223
Autelitano, F., see Weill, C. (333) 269 Fujiwara, T., see Inamura, N. (333) 79
Gagov, H.S., see Duridanova, D.B. (333) 105
Badran, S., Schmutz, M. and Olpe, H.-R.
Giuliani, S., Tramontana, M., Lecci, A. and Maggi, C.A.
Comparative in vivo and in vitro studies with the potent GABA,
Effect of nociceptin on heart rate and blood pressure in anaesthetized
receptor antagonist, CGP 56999A (333) 135
rats (333) 177
Berthiaume, N., Hess, F., Chen, A., Regoli, D. and D’Orléans-Juste, P.
Goeldner, M., see Weill, C. (333) 269
Pharmacology of kinins in the arterial and venous mesenteric bed of
Gordon, FJ., see Patterson, A.B. (333) 47
normal and B, knockout transgenic mice (333) 55
Giren, Z., see Aslan, N. (333) 63
Berto, L., see Cortijo, J. (333) 69
Goto, W., see Kageyama, M. (333) 223
Bodaiji, N., see Miyamoto, S. (333) 279
Boev, K.K., see Duridanova, D.B. (333) 105 Grau, M., see Cortijo, J. (333) 69
Gualix, J., see Hoyle, C.H.V. (333) RI
Bone, H.-G., see Waurick, R. (333) 181
Guenet, C., see Weill, C. (333) 269
Booke, M., see Waurick, R. (333) 181
Borgbjerg, F.M., see Ebert, B. (333) 99 Gyérgy, K., see Vegh, A. (333) 33
Bosker, F.J., Klompmakers, A. and Westenberg, H.G.M.
Haniuda, K., Nakane, T. and Chiba, S.
Postsynaptic 5-HT,, receptors mediate 5-hydroxytryptamine release
Different contributions of ATP and noradrenaline to neurotransmis-
in the amygdala through a feedback to the caudal linear raphe (333)
sion in the isolated canine intermediate auricular artery (333) 163
147
Hashizume, H., see Chen, M. (333) 261
Hatori, C., see Inamura, N. (333) 79
Carrasco, E., see Cortijo, J. (333) 69 Heitz, F., see Weill, C. (333) 269
Chariot, J., see Souli, A. (333) 87 Hess, F., see Berthiaume, N. (333) 55
Chen, A., see Berthiaume, N. (333) 55 Hirabayashi, N., see Ishizaki, K. (333) 207
Chen, M., Xiao, C.-Y., Hashizume, H. and Abiko, Y. Hirosumi, J., see Inamura, N. (333) 79
Differential effects of Ca** channel blockers on Ca’* overload Hjalmarson, A., see Skomedal, T. (333) 169
induced by lysophosphatidylicholine in cardiomyocytes (333) 261 Hoebeke, J., see Skomedal, T. (333) 169
Chiba, S., see Haniuda, K. (333) 163 Holtzman, S.G., see Patterson, A.B. (333) 47
Cortijo, J., Marti-Cabrera, M., Berto, L., Antén, F., Carrasco, E., Grau, Hoyle, C.H.V., Pintor, J., Gualix, J. and Miras-Portugal, M.T.
M. and Morcillo, EJ.
Antagonism of P2X receptors in guinea-pig vas deferens by diinosine
Pharmacological activity of PF-904 in guinea pig in vivo, and on pentaphosphate (333) R1
human bronchus and neutrophils in vitro (333) 69
Curzon, G., see Datla, K.P. (333) 27 llien, B., see Weill, C. (333) 269
Imafuku, J., see Miyamoto, S. (333) 279
Dahl, R., see Thirstrup, S. (333) 215 Inada, H., see Matsushima, S. (333) 93
Datla, K.P. and Curzon, G. Inamura, N., Asano, M., Hatori, C., Sawai, H., Hirosumi, J., Fujiwara, T..
The effect of p-fenfluramine on brain 5-hydroxytryptamine and 5-hy- Kayakiri, H., Satoh, S., Abe, Y., Inoue, T., Sawada, Y., Oku, T. and
droxyindoleacetic acid in male and female rats (333) 27 Nakahara, K.
294 Author index
Pharmacological characterization of a novel, orally active, nonpeptide Nagata, N., see Inoue, H. (333) 231
bradykinin B, receptor antagonist, FR167344 (333) 79 Nagatani, T., see Takao, K. (333) 123
Inoue, H., Asaka, T., Nagata, N. and Koshihara, Y. Naka, M., see Matsushima, S. (333) 93
Mechanism of mustard oil-induced skin inflammation in mice (333) Nakahara, K., see Inamura, N. (333) 79
231 Nakane, T., see Haniuda, K. (333) 163
Inoue, T., see Inamura, N. (333) 79 Nakata, K., see Kageyama, M. (333) 223
Ishiguro, I., see Nishida, K. (333) 289 Nasu, T. and Shibata, A.
Ishiyama, Y., see Khan, A.I. (333) 187 Na*-independent glucose utilization during Mn**-induced contrac-
Ishizaki, K., Kinbara, S., Miyazawa, N., Takeuchi, Y., Hirabayashi, N.., tion in ileal longitudinal smooth muscle (333) 199
Kasai, H. and Araki, T. Nielsen-Kudsk, F., see Thirstrup, S. (333) 215
Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunc- Nishida, K., Ohta, Y. and Ishiguro, I.
tion in bile duct-ligated rats (333) 207 Glycine facilitates y-glutamylcysteinylethy! ester-mediated increase in
lyengar, S., see Pheng, L.H. (333) R3 liver glutathione level (333) 289
Kageyama, M., Fujita, H., Goto, W., Nakata, K., Shirasawa, E. and Ohta, Y., see Nishida, K. (333) 289
Kanai, A. Oktay, §., see Aslan, N. (333) 63
FK506-binding proteins regulate smooth muscle contractility by alter- Oku, T., see Inamura, N. (333) 79
ing neurotransmitter release (333) 223 Olpe, H.-R., see Badran, S. (333) 135
Kanai, A., see Kageyama, M. (333) 223 Onat, F., see Aslan, N. (333) 63
Kangawa, K., see Khan, A.1. (333) 187 Osada, K., see Miyamoto, S. (333) 279
Kasai, H., see Ishizaki, K. (333) 207 Osnes, J.-B., see Skomedal, T. (333) 169
Kaszala, K., see Vegh, A. (333) 33
Kato, J., see Khan, A.I. (333) 187 Papp, J.G., see Vegh, A. (333) 33
Katsube, Y., see Yokoshiki, H. (333) 249 Parratt, J.R., see Vegh, A. (333) 33
Kayakiri, H., see Inamura, N. (333) 79 Patterson, A.B., Gordon, FJ. and Holtzman, S.G.
Kendall, D.A., see Randall, M.D. (333) 191 Naltrindole, a selective 5-opioid receptor antagonist, potentiates the
Khan, A.L., Kato, J., Ishiyama, Y., Kitamura, K., Kangawa, K. and Eto, lethal effects of cocaine by a central mechanism of action (333) 47
1 2 Pézzola, A., see Popoli, P. (333) 143
Effect of chronically infused adrenomedullin in two-kidney, one-clip Pheng, L.H., Quirion, R., lyengar, S., Fournier, A. and Regoli, D.
hypertensive rats (333) 187 The rabbit ileum: A sensitive and selective preparation for the neu-
Kinbara, S., see Ishizaki, K. (333) 207 ropeptide Y Y, receptor (333) R3
Kitamura, K., see Khan, A.I. (333) 187 Pintor, J., see Hoyle, C.H.V. (333) RI
Kitamura, Y., see Takao, K. (333) 123 Popoli, P., Reggio, R. and Pézzola, A.
Klompmakers, A., see Bosker, F.J. (333) 147 Adenosine A, and A, receptor agonists significantly prevent the
Koshihara, Y., see Inoue, H. (333) 231 electroencephalographic effects induced by MK-801 in rats (333) 143
Kubova, H., Vilagi, I., Mikuleck4, A. and Mare, P. Presset, O., see Souli, A. (333) 87
Non-NMDA receptor antagonist GYKI 52466 suppresses cortical Prien, T., see Waurick, R. (333) 181
afterdischarges in immature rats (333) 17
Quirion, R., see Pheng, L.H. (333) R3
Leander, J.D., see Wolff, M.C. (333) 113
Lecci, A., see Giuliani, S$. (333) 177 Randall, M.D., McCulloch, A.I. and Kendall, D.A.
Lin, R.-H., see Liu, S.-H. (333) 241 Comparative pharmacology of endothelium-derived hyperpolarizing
Lin-Shiau, S.-Y., see Liu, S.-H. (333) 241 factor and anandamide in rat isolated mesentery (333) 191
Liu, S.-H., Sheu, Z.-J., Lin, R.-H. and Lin-Shiau, S.-Y. Reggio, R., see Popoli, P. (333) 143
The in vivo effect of lipopolysaccharide on neuromuscular transmis- Regoli, D., see Berthiaume, N. (333) 55
sion in the mouse (333) 241 Regoli, D., see Pheng, L.H. (333) R3
Reid, A.R., see Sawynok, J. (333) |
Maggi, C.A., see Giuliani, S$. (333) 177 Riekkinen Jr., P., see Aura, J. (333) 129
MareS, P., see Kubova, H. (333) 17 Rozé, C., see Souli, A. (333) 87
Marti-Cabrera, M., see Cortijo, J. (333) 69 Ruiz-Ortega, J.A. and Ugedo, L.
Matsushima, S., Inada, H., Asai, T., Naka, M. and Tanaka, T. Activation of 5-HT,, receptors potentiates the clonidine inhibitory
Propiverine hydrochloride, an anti-pollakiuric agent, inhibits the activ- effect in the locus coeruleus (333) 159
ity of actomyosin ATPase from the urinary bladder (333) 93
Mayet, S., see Diaz, A. (333) 9 Sasuga, Y., see Miyamoto, S. (333) 279
McCulloch, A.I., see Randall, M.D. (333) 191 Satoh, S., see Inamura, N. (333) 79
MeiBner, A., see Waurick, R. (333) 181 Sawada, Y., see Inamura, N. (333) 79
Meyer, J., see Waurick, R. (333) 181 Sawai, H., see Inamura, N. (333) 79
Mikkelsen, S., see Ebert, B. (333) 99 Sawynok, J., Zarrindast, M.-R., Reid, A.R. and Doak, G.J.
Mikulecka, A., see Kubova, H. (333) 17 Adenosine A , receptor activation produces nociceptive behaviour and
Miras-Portugal, M.T., see Hoyle, C.H.V. (333) R1 edema by release of histamine and 5-hydroxytryptamine (333) |
Miyamoto, S., Asakura, M., Sasuga, Y., Osada, K., Bodaiji, N., Imafuku, Schiander, 1.G., see Skomedal, T. (333) 169
J. and Aoba, A. Schmutz, M., see Badran, S. (333) 135
Effects of long-term treatment with desipramine on microtubule pro- Sheu, Z.-J., see Liu, S.-H. (333) 241
teins in rat cerebral cortex (333) 279 Shibata, A., see Nasu, T. (333) 199
Miyazawa, N., see Ishizaki, K. (333) 207 Shirasawa, E., see Kageyama, M. (333) 223
Morcillo, E.J., see Cortijo, J. (333) 69 Sirvié, J., see Aura, J. (333) 129
Author index
Skomedal, T., Fu, M.L.X., Hjalmarson, A., Hoebeke, J., Schiander, LG Vegh, A.. Papp, J.G., GyGrgy, K.. Kaszala, K. and Parratt, J.R.
and Osnes, J.-B. Does the opening of ATP-sensitiveK * chanmodnifye islchasemi a-
Anti-M, muscarinic receptor antibodies inhibit B-adrenoceptor-medi- induced ventricular arrhythmias in anaesthetised dogs? (333) 33
ated inotropic response in rat myocardium (333) 169 Vilégi, 1., see Kubové, H. (333) 17
Souli, A., Chariot, J., Presset, O., Tsocas, A. and Rozé, C.
Neural modulation of the antisecretory effect of peptide YY in the rat Waurick, R., Bone, H.-G., Meyer, J., Booke, M., Meifner, A., Prien, T.
jejunum (333) 87 and Van Aken, H.
Sperelakis, N., see Yokoshiki, H. (333) 249 Haemodynamic effects of dopexamine and nitric oxide synthase
Sunagawa, M., see Yokoshiki, H. (333) 249 inhibition in healthy and endotoxaemic sheep (333) 181
Weill, C., Autelitano, F., Guenet, C., Heitz, F_. Goeldner, M. and Hien, B.
Takao, K., Nagatani, T., Kitamura, Y. and Yamawaki, S. Pharmanad sctructourall inotegrgity iof cmuscaarilnic M, acetyl-
Effects of corticosterone on 5-HT,, and 5-HT, receptor binding and choline receptors produced in Sf9 insect cells (333) 269
on the receptor-mediated behavioral responses of rats (333) 123 Westenberg, H.G.M., see Bosker, FJ. (333) 147
Takeuchi, Y., see Ishizaki, K. (333) 207 Wolff, M.C. and Leander, J.D.
Tanaka, T., see Matsushima, S. (333) 93 Differentiation of 5-HT,, receptor ligands by drug discrimination
Thirstrup, S., Dahl, R. and Nielsen-Kudsk, F (333) 113
Interaction between prostaglandins and selective phosphodiesterase
inhibitors in isolated guinea-pig trachea in vitro (333) 215 Xiao, C.-Y., see Chen, M. (333) 261
Thorkildsen, C., see Ebert, B. (333) 99
Tramontana, M., see Giuliani, S. (333) 177 Yamawaki, S., see Takao, K. (333) 123
Tsocas, A., see Souli, A. (333) 87 Yokoshiki, H., Katsube, Y.. Sunagawa, M. and Sperelakis, N.
Levosimendan, a novel Ca’* sensitizer, activates the glibenclamide-
Ugedo, L., see Ruiz-Ortega, J.A. (333) 159 sensitive K* channel in rat arterial myocytes (333) 249
Van Aken, H., see Waurick, R. (333) 181 Zarrindast, M.-R., see Sawynok, J. (333) |

co
European Journal of Pharmacology 333 (1997) 297-303
Keyword index
Actomyosin ATPase activity Anandamide
P-4 (1-methyl-4-piperidy! diphenylpropoxyacetate hydrochloride); Anti- Endothelium; EDHF (endothelium-derived hyperpolarizing factor), K*
pollakiuric agent; Urinary bladder; Smooth muscle; Calmodulin channel; Cytochrome P-450 inhibitor; Cannabinoid (Randall, M.D. (333)
(Matsushima, S. (333) 93) 191)
Adenosine A , receptor Angiotensin II
Pain; Histamine; 5-HT (S-hydroxytryptamine, serotonin) (Sawynok, J. Enalapril; L-nitro-arginine methyl ester (L-NAME), Nitric oxide (NO),
(333) 1) Stroke (Ahmad, S. (333) 39)
Adenosine receptor
Antibody
MK-801 ((+ )-5-methyl-10,1 1-dihydro-SH-dibenzo-(a,d cyclohepten-
Muscarinic M, receptor; Peptide; Inotropic effect; Papillary muscle
5,10-imine maleate), Electroencephalogram; (Rat) (Popoli, P. (333) 143) (Skomedal, T. (333) 169)
a ,-Adrenoceptor
Anticonvulsant action
Peptide YY; Intestinal secretion; VIP (vasoactive intestinal peptide),
GYKI 52466 (1-(4-aminopheny!)-4-methyl-7,8-methylendioxy-SH-2,3-
Intestinal nerve; o@ Receptor; (Rat) (Souli, A. (333) 87)
benzo-diazepine), Excitatory amino acid; Motor system; Flumazenil
(Kubova, H. (333) 17)
a ,,-Adrenoceptor
Locus coeruleus; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)-tetralin),
ARC 239 (2-{2-[4-(0-methoxyphen|y- y!lJ)etphiy!p}-e4,r4-adzimietnhy-|- Antidepressant
1,3(2H,4H)-isoquinolinedione); Chlorpromazine (Ruiz-Ortega, J.A. (333) Desipramine; Microtubule-associated protein 2; Microtubule assembly;
159) Phosphorylation (Miyamoto, S. (333) 279)
Adrenomedullin Anti-pollakiuric agent
Blood pressure; Renovascular hypertension; Renin; Aldosterone; (Rat) P-4 (\-methyl-4-piperidy! diphenylpropoxyacetate hydrochloride), Uri-
(Khan, A.1. (333) 187) nary bladder; Smooth muscle; Actomyosin ATPase activity; Calmodulin
(Matsushima, S. (333) 93)
Airway
PF-904; Airway, hyperreactivity; Eosinophil infiltration; Microvascular Apamin
leakage; Bronchus, human, isolated; Phosphodiesterase activity; Neu- Smooth muscle; K* channels; Ca?* stores; Charybdotoxin; Pacemaker
trophils, human; Superoxide anion generation; (Guinea pig) (Cortijo, J. cells (Duridanova, D.B. (333) 105)
(333) 69)
ARC 239 (2-[2-[4-(0-methoxypheny!)piperazin-1-yllethy!]-4,4-di-
Airway, hyperreactivity methyl- 13 (2H,4H)-isoquinolinedione)
PF-904; Airway; Eosinophil infiltration; Microvascular leakage; Bronchus, Locus coeruleus; a,,-Adrenoceptor,; 8-OH-DPAT (8-hydroxy-2-(di-n-
human, isolated; Phosphodiesterase activity; Neutrophils, human; Super- propylamino)-tetralin), Chlorpromazine (Ruiz-Ortega, J.A. (333) 159)
oxide anion generation; (Guinea pig) (Cortijo, J. (333) 69)
Arrhythmia
Airway tone, spontaneous Ischaemia; K* channel activator; Levcromakalim; Reperfusion (Vegh, A.
Smooth muscle, airway; Phosphodiesterase inhibitor, Prostaglandin; (333) 33)
(Guinea pig) (Thirstrup, S. (333) 215)
Aldosterone Aryldiazonium salt
Muscarinic receptor; Muscarinic receptor, m2 subtype; Sf9 cells; Cova-
Adrenomedullin; Blood pressure; Renovascular hypertension; Renin; (Rat)
lent labelling (Weill, C. (333) 269)
(Khan, A.1. (333) 187)
Alzheimer’s disease Ascomycin
Muscarinic M, receptor; Muscarinic M, receptor, Scopolamine; Piren- FK506-binding protein; Neurotransmitter release; Smooth muscle con-
zepine; Methoctramine; (Delay-dependent and -independent); (% correct traction; Tachykininergic nerve; Iris sphincter muscle, rabbit (Kageyama,
choice) (Aura, J. (333) 129) M. (333) 223)
Amygdala, central nucleus of ATP
Muscarinic M, receptor; Carbachol; Blood pressure; (Rat) (Aslan, N. Diadenosine pentaphosphate; Diinosine pentaphosphate (Hoyle, C.H.V.
(333) 63) (333) RI)
298 Keyword index
Auricular artery Ca** overload
Sympathetic nerve stimulation; Purinergic transmission; P, , purinoceptor Cardiomyocyte; Lysophosphatidylcholine; Ca** channel blocker; Crea-
(Haniuda, K. (333) 163) tine kinase (Chen, M. (333) 261)
Bile duct ligation Ca** stores
Sodium tauroursodeoxycholate (UR-906); Dehydrocholic acid; Blood co- Smooth muscle; K* channels; Charybdotoxin; Apamin; Pacemaker cells
agulation factor; Cholestasis; (Rat) (Ishizaki, K. (333) 207) (Duridanova, D.B. (333) 105)
B, knockout mice Calmodulin
Vasodilation; Vasoconstriction; Bradykinin; Bradykinin receptor; Mesen- P-4 (1-methyl-4-piperidy! diphenylpropoxyacetate hydrochloride); Anti-
teric bed (Berthiaume, N. (333) 55)
pollakiuric agent; Urinary bladder; Smooth muscle; Actomyosin ATPase
activity (Matsushima, S. (333) 93)
Blood coagulation factor
Bile duct ligation; Sodium tauroursodeoxycholate (UR-906); Dehydro-
Cannabinoid
cholic acid; Cholestasis; (Rat) (Ishizaki, K. (333) 207)
Endothelium; EDHF (endothelium-derived hyperpolarizing factor); Anan-
damide; K* channel; Cytochrome P-450 inhibitor (Randall, M.D. (333)
Blood pressure
Adrenomedullin; Renovascular hypertension; Renin; Aldosterone; (Rat) 191)
(Khan, A.I. (333) 187)
Capsaicin
Muscarinic M, receptor; Carbachol; Amygdala, central nucleus of; (Rat) Mustard oil; Neurogenic inflammation; Plasma extravasation; Ear oedema;
(Aslan, N. (333) 63) SR 140333 (Inoue, H. (333) 231)
Nociceptin; Hypotension; Heart rate; Vagal bradycardia (Giuliani, S. Carbachol
(333) 177) Muscarinic M, receptor; Blood pressure; Amygdala, central nucleus of;
(Rat) (Aslan, N. (333) 63)
Opioid; Cocaine; Lethality; Cardiovascular; Seizure (Patterson, A.B. (333)
47) Cardiomyocyte
Lysophosphatidylcholine; Ca?* overload; Ca’* channel blocker; Crea-
Body temperature tine kinase (Chen, M. (333) 261)
Corticosterone; 5-HT,, receptor; 5-HT, receptor; 5-HT (5-hydroxy-
tryptamine, serotonin) syndrome; Wet-dog shake (Takao, K. (333) 123)
Cardiovascular
Bradykinin Opioid; Cocaine; Lethality; Blood pressure; Seizure (Patterson, A.B.
(333) 47)
Bradykinin receptor antagonist; FR167344; FR172357; Bradykinin B,
receptor; Orally active (Inamura, N. (333) 79)
CGP 56999A
GABA, receptors; Epilepsy (rat); brain slices (Badran, S. (333) 135)
Vasodilation; Vasoconstriction; Bradykinin receptor; Mesenteric bed; B,
knockout mice (Berthiaume, N. (333) 55)
Charybdotoxin
Bradykinin B, receptor Smooth muscle; K* channels; Ca** stores; Apamin; Pacemaker cells
Bradykinin; Bradykinin receptor antagonist; FR 167344; FR172357; Orally (Duridanova, D.B. (333) 105)
active (Inamura, N. (333) 79)
Chlorpromazine
Bradykinin receptor Locus coeruleus; a,,-Adrenoceptor, 8-OH-DPAT (8-hydroxy-2-(di-n-
Vasodilation; Vasoconstriction; Bradykinin; Mesenteric bed; B, knockout propylamino)-tetralin); ARC 239 (2-(2-[4-(o-methoxyphenyl)piperazin-| -
mice (Berthiaume, N. (333) 55) ylJethy!]}-14, 3,(24H,-4Hd)-iisomqueintolhinyedlio-ne ) (Ruiz-Ortega, J.A.
(333) 159)
Bradykinin receptor antagonist
Bradykinin; FR167344; FR172357; Bradykinin B, receptor; Orally active Cholestasis
(Inamura, N. (333) 79) Bile duct ligation; Sodium tauroursodeoxycholate (UR-906); Dehydro-
cholic acid; Blood coagulation factor; (Rat) (Ishizaki, K. (333) 207)
Brain slices
GABA, receptors; CGP 56999A; Epilepsy (rat) (Badran, S. (333) 135)
Cocaine
Bronchus, human, isolated Opioid; Lethality; Cardiovascular; Blood pressure; Seizure (Patterson,
A.B. (333) 47)
PF-904; Airway; Airway, hyperreactivity; Eosinophil infiltration; Mi-
crovascular leakage; Phosphodiesterase activity; Neutrophils, human; Su-
Cortex, rat
peroxide anion generation; (Guinea pig) (Cortijo, J. (333) 69)
NMDA receptor antagonist, non-competitive; Electrophysiology; Spinal
BU-224 (2-(4,5-dihydroimidazol-2yl)-quinoline hydrochloride)) cord, rat; Enantiomer (Ebert, B. (333) 99)
as
Imidazoline receptor; Nociception; Spinal cord; (Rat) (Diaz, A. (333) 9)
Corticosterone
Ca?* channel 5-HT,, receptor; 5-HT, receptor; Body temperature; 5-HT (5-hydroxy-
Mn?*; Ileum; Smooth muscle (Nasu, T. (333) 199) tryptamine, serotonin) syndrome; Wet-dog shake (Takao, K. (333) 123)
Ca** channel blocker Covalent labelling
Cardiomyocyte; Lysophosphatidylcholine; Ca** overload; Creatine ki- Muscarinic receptor; Muscarinic receptor, m2 subtype; Sf9 cells; Aryldia-
nase (Chen, M. (333) 261) zonium salt (Weill, C. (333) 269)
Keyword index
Creatine kinase Eosinophil infiltration
Cardiomyocyte; Lysophosphatidylcholine; Ca** overload; Ca** channel PF-904; Airway; Airway, hyperreactivity; Microvascular leakage:
blocker (Chen, M. (333) 261) Bronchus, human, isolated; Phosphodiesterase activity; Neutrophils, hu-
man; Superoxide anion generation; (Guinea pig) (Cortijo, J. (333) 69)
Cytochrome P-450 inhibitor
Endothelium; EDHF (endothelium-derived hyperpolarizing factor), Anan- Epilepsy (rat)
damide; K* channel; Cannabinoid (Randall, M.D. (333) 191) GABA, receptors; CGP 56999A; brain slices (Badran, S$. (333) 135)
Dehydrocholic acid Excitaatmionor ayci d
Bile duct ligation; Sodium tauroursodeox ycholate (UR-906), Blood coag- GYKI 52466 (1-44-aminophenyl)-4-methy!-7,8-methylendioxy-SH-2,3-
ulation factor; Cholestasis; (Rat) (Ishizaki, K. (333) 207)
benzo-diazepine); Anticonvulsant action; Motor system; Flumazenil
(Kubova, H. (333) 17)
Desipramine
Antidepressant; Microtubule-associated protein 2; Microtubule assembly;
Feedback regulation
Phosphorylation (Miyamoto, S. (333) 279)
Flesinoxan; WAY 100635; 5-HT (S-hydroxytryptamine, serotonin), 5-
HT,, receptor; Microdialysis; (Rat) (Bosker, FJ. (333) 147)
Diadenosine pentaphosphate
Diinosine pentaphosphate; ATP (Hoyle, C.H.V. (333) R1)
D-Fenfluramine
5-HT (5-hydroxytryptamine, serotonin), D-Norfenfluramine; Sex differ-
Diinosine pentaphosphate
ence (Datla, K.P. (333) 27)
Diadenosine pentaphosphate; ATP (Hoyle, C.H.V. (333) RI)
FK506-binding protein
Dopexamine
Endotoxaemia; Hyperdynamic circulation; Nitric oxide (NO) synthase Ascomycin, Neurotransmitter release; Smooth muscle contraction;
inhibition (Waurick, R. (333) 181) Tachykininergic nerve; Iris sphincter muscle, rabbit (Kageyama, M. (333)
223)
Drug discrimination
5-HT,, receptor; Efficacy; (Pigeon) (Wolff, M.C. (333) 113) Flesinoxan
WAY 100635; 5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptor;
Ear oedema Feedback regulation; Microdialysis; (Rat) (Bosker, FJ. (333) 147)
Mustard oil; Neurogenic inflammation; Plasma extravasation; Capsaicin;
SR 140333 (Inoue, H. (333) 231) Flumazenil
GYKI 52466 (1-(4-aminopheny!)-4-methyl-7,8-methylendioxy-SH-2,3-
EDHF (endothelium-derived hyperpolarizing factor) benzo-diazepine), Excitatory amino acid; Anticonvulsant action; Motor
Endothelium; Anandamide; K* channel; Cytochrome P-450 inhibitor; system (Kubova, H. (333) 17)
Cannabinoid (Randall, M.D. (333) 191)
FR167344
Efficacy Bradykinin; Bradykinin receptor antagonist; FR172357; Bradykinin B,
5-HT,, receptor; Drug discrimination; (Pigeon) (Wolff, M.C. (333) 113) receptor, Orally active (Inamura, N. (333) 79)
Electroencephalogram FR172357
Adenosine receptor; MK-801 ((+ )-5-methyl-10,1 1-dihydro-SH-dibenzo- Bradykinin; Bradykinin receptor antagonist; FR167344; Bradykinin B,
(a,d)cyclohepten-5,10-imine maleate); (Rat) (Popoli, P. (333) 143) receptor; Orally active (Inamura, N. (333) 79)
GABA, receptors
NMDA receptor antagonist, non-competitive; Cortex, rat; Spinal cord, rat; CGP 56999A; Epilepsy (rat); brain slices (Badran, S. (333) 135)
Enantiomer (Ebert, B. (333) 99)
y-Glutamyicysteinyletehsytle r
Enalapril
Glutathione, reduced; Hepatocyte; Glycine; Tert-butyl hydroperoxide
Angiotensin Il; L-nitro-arginine methyl ester (L-NAME), Nitric oxide (Nishida, K. (333) 289)
(NO), Stroke (Ahmad, S. (333) 39)
Glutathione, reduced
Enantiomer
y-glutamylcysteinylethyl ester; Hepatocyte; Glycine; Tert-buty! hydroper-
NMDA receptor antagonist, non-competitive; Electrophysiology; Cortex,
oxide (Nishida, K. (333) 289)
rat; Spinal cord, rat (Ebert, B. (333) 99)
Endothelium Glycine
EDHF (endothelium-derived hyperpolarizing factor), Anandamide; K* y-glutamylcysteinylethy! ester; Glutathione, reduced; Hepatocyte; Tert-
channel; Cytochrome P-450 inhibitor; Cannabinoid (Randall, M.D. (333) butyl hydroperoxide (Nishida, K. (333) 289)
191)
GYKI 52466 (1-(4-aminophenyl)-4-methy!-7,8-methylendioxy-SH-
Endotoxaemia 2,3-benzo-diazepine)
Hyperdynamic circulation; Nitric oxide (NO) synthase inhibition, Dopex- Excitatory amino acid; Anticonvulsant action; Motor system; Flumazenil
amine (Waurick, R. (333) 181) (Kubova, H. (333) 17)
Endotoxin Heart rate
Neostigmine; Neurotransmission; Na*, K *-ATPase; N°-nitro-L-arginine Nociceptin; Blood pressure; Hypotension; Vagal bradycardia (Giuliani, S.
(Liu, S.-H. (333) 241) (333) 177)
300 Keyword index
Hepatocyte Ischaemia
y-glutamylcysteinylethyl ester; Glutathione, reduced; Glycine; Tert-buty! Arrhythmia; K* channel activator, Levcromakalim; Reperfusion (Vegh,
hydroperoxide (Nishida, K. (333) 289) A. (333) 33)
Histamine K * channel
Adenosine A, receptor; Pain; 5-HT (S-hydroxytryptamine, serotonin) Endothelium; EDHF (endothelium-derived hyperpolarizing factor), Anan-
(Sawynok, J. (333) 1) damide; Cytochrome P-450 inhibitor; Cannabinoid (Randall, M.D. (333)
191)
5-HT (5-hydroxytryptamine, serotonin) syndrome
Corticosterone; 5-HT,, receptor; 5-HT, receptor; Body temperature; Levosimendan; K* channel, ATP-sensitive; Patch clamp technique;
Wet-dog shake (Takao, K. (333) 123) Mesenteric artery, rat (Yokoshiki, H. (333) 249)
5-HT (5-hydroxytryptamine, serotonin) K * channel activator
p-Fenfluramine; D-Norfenfluramine; Sex difference (Datla, K.P. (333) 27) Arrhythmia; Ischaemia; Levcromakalim; Reperfusion (Vegh, A. (333) 33)
Adenosine A, receptor; Pain; Histamine (Sawynok, J. (333) 1) K * channel, ATP-sensitive
Levosimendan; K* channel; Patch clamp technique; Mesenteric artery,
Flesinoxan; WAY 100635; 5-HT,, receptor; Feedback regulation; Micro- rat (Yokoshiki, H. (333) 249)
dialysis; (Rat) (Bosker, F.J. (333) 147)
K * channels
5-HT,, receptor
Smooth muscle; Ca** stores; Charybdotoxin; Apamin; Pacemaker cells
Corticosterone; 5-HT, receptor; Body temperature; 5-HT (5-hydroxy- (Duridanova, D.B. (333) 105)
tryptamine, serotonin) syndrome; Wet-dog shake (Takao, K. (333) 123)
Lethality
Efficacy; Drug discrimination; (Pigeon) (Wolff, M.C. (333) 113)
Opioid; Cocaine; Cardiovascular; Blood pressure; Seizure (Patterson,
A.B. (333) 47)
Flesinoxan; WAY 100635; 5-HT (S-hydroxytryptamine, serotonin); Feed-
back regulation; Microdialysis; (Rat) (Bosker, FJ. (333) 147)
Levcromakalim
Arrhythmia; Ischaemia; K* channel activator; Reperfusion (Vegh, A.
5-HT, receptor
(333) 33)
Corticosterone; 5-HT,, receptor; Body temperature; 5-HT (5-hydroxy-
tryptamine, serotonin) syndrome; Wet-dog shake (Takao, K. (333) 123)
Levosimendan
K* channel; K* channel, ATP-sensitive; Patch clamp technique; Mesen-
Hyperdynamic circulation
teric artery, rat (Yokoshiki, H. (333) 249)
Endotoxaemia; Nitric oxide (NO) synthase inhibition; Dopexamine
(Waurick, R. (333) 181)
Locus coeruleus
a@,,-Adrenoceptor; 8-OH-DPAT (8-hydroxy-2-di-n-propylamino)-tetra-
Hypotension
lin); ARC 239 (2-[2-[4-(0-methoxypheny!)|p- yilJpetehry!a}-z4i,4n-d-i-
Nociceptin; Blood pressure; Heart rate; Vagal bradycardia (Giuliani, S.
(333) 177) methyl-!,3(2H,4H)-isoquinolinedione), Chlorpromazine (Ruiz-Ortega,
J.A. (333) 159)
lleum
Mn?*; Smooth muscle; Ca?* channel (Nasu, T. (333) 199) Lysophosphatidyicholine
Cardiomyocyte; Ca** overload; Ca** channel blocker; Creatine kinase
Neuropeptide Y; Neuropeptide Y Y,; receptor; (Rabbit) (Pheng, L.H. (Chen, M. (333) 261)
(333) R3)
Mesenteric artery, rat
Imidazoline receptor Levosimendan; K* channel; K* channel, ATP-sensitive; Patch clamp
BU-224 (2-(4,5-dihydroimidazol-2yl)-quinoline hydrochloride)); Nocicep- technique (Yokoshiki, H. (333) 249)
tion; Spinal cord; (Rat) (Diaz, A. (333) 9)
Mesenteric bed —
Inotropic effect Vasodilation; Vasoconstriction; Bradykinin; Bradykinin receptor; B,
Muscarinic M, receptor; Antibody; Peptide; Papillary muscle (Skomedal, knockout mice (Berthiaume, N. (333) 55)
T. (333) 169)
Methoctramine
Intestinal nerve Muscarinic M, receptor; Muscarinic M, receptor; Scopolamine; Piren-
Peptide YY; Intestinal secretion; VIP (vasoactive intestinal peptide), zepine, Alzheimer’s disease; (Delay-dependent and -independent), (%
a,-Adrenoceptor, @ Receptor; (Rat) (Souli, A. (333) 87) correct choice) (Aura, J. (333) 129)
Intestinal secretion M
Peptide YY; VIP (vasoactive intestinal peptide); Intestinal nerve; a,- Flesinoxan; WAY 100635; 5-HT (S-hydroxytryptamine, serotonin); 5-
Adrenoceptor; a Receptor; (Rat) (Souli, A. (333) 87) HT,, receptor; Feedback regulation; (Rat) (Bosker, FJ. (333) 147)
Iris sphincter muscle, rabbit Microtubule assembly
Ascomycin; FK506-binding protein; Neurotransmitter release; Smooth Antidepressant; Desipramine; Microtubule-associated protein 2; Phospho-
muscle contraction; Tachykininergic nerve (Kageyama, M. (333) 223) rylation (Miyamoto, S. (333) 279)
Keyword index
Microtubule-associated protein 2 Neuropeptide Y Y, receptor
Antidepressant; Desipramine; Microtubule assembly; Phosphorylation lleum; Neuropeptide Y; (Rabbit) (Pheng, L.H. (333) R3)
(Miyamoto, S. (333) 279)
Microvascular leakage Endotoxin; Neostigmine; Na*, K*-ATPase; N°-nitro-t-arginine (Liu,
PF-904, Airway; Airway, hyperreactivity; Eosinophil infiltration; S.-H. (333) 241)
Bronchus, human, isolated; Phosphodiesterase activity; Neutrophils, hu-
man; Superoxide anion generation; (Guinea pig) (Cortijo, J. (333) 69) Neurotransmitter release
Ascomycin,; FK506-binding protein; Smooth muscle contraction;
MK-801 (( + )-5-methyl-10,11-dihydro-SH-dibenzo-(a,d)cyclohepten- Tachykininergic nerve; Iris sphincter muscle, rabbit (Kageyama, M. (333)
5,10-imine maleate) 223)
Adenosine receptor; Electroencephalogram; (Rat) (Popoli, P. (333) 143)
Neutrophils, human
Mn’*
PF-904, Airway; Airway, hyperreactivity; Eosinophil infiltration; Mi-
Ileum; Smooth muscle; Ca** channel (Nasu, T. (333) 199)
crovascular leakage; Bronchus, human, isolated; Phosphodiesterase activ-
ity; Superoxide anion generation; (Guinea pig) (Cortijo, J. (333) 69)
Motor system
GYKI 52466 (1-(4-aminopheny!)-4-methyl-7,8-methylendioxy-5H-2,3- Nitric oxide (NO)
benzo-diazepine); Excitatory amino acid; Anticonvulsant action; Angiotensin II; Enalapril; L-nitro-arginine methy! ester (L-NAME), Stroke
Flumazenil (Kubova, H. (333) 17)
(Ahmad, S. (333) 39)
Muscarinic M, receptor
Nitric oxide (NO) synthase inhibition
Carbachol; Blood pressure; Amygdala, central nucleus of; (Rat) (Aslan,
Endotoxaemia; Hyperdynamic circulation; Dopexamine (Waurick, R.
N. (333) 63)
(333) 181)
Muscarinic M, receptor, Scopolamine; Pirenzepine, Methoctramine; N°-Nitro-t-arginine
Alzheimer's disease; (Delay-dependent and -independent), (% correct
Endotoxin; Neostigmine; Neurotransmission; Na*, K*-ATPase (Liu, S.-
choice) (Aura, J. (333) 129)
H. (333) 241)
Muscarinic M, receptor
NMDA receptor antagonist, non-competitive
Antibody; Peptide; Inotropic effect; Papillary muscle (Skomedal, T. (333)
Electrophysiology; Cortex, rat; Spinal cord, rat; Enantiomer (Ebert, B.
169)
(333) 99)
Muscarinic M, receptor, Scopolamine; Pirenzepine; Methoctramine;
Nociceptin
Alzheimer’s disease; (Delay-dependent and -independent); (% correct
choice) (Aura, J. (333) 129) Blood pressure; Hypotension; Heart rate; Vagal bradycardia (Giuliani, S.
(333) 177)
Muscarinic receptor
Muscarinic receptor, m2 subtype; Sf9 cells; Covalent labelling; Aryldia- Nociception
zonium salt (Weill, C. (333) 269) Imidazoline receptor, BU-224 (244,5-dihydroimidazol-2yl)-quinoline hy-
drochloride)), Spinal cord; (Rat) (Diaz, A. (333) 9)
Muscarinic receptor, m2 subtype
D-Norfenfluramine
Muscarinic receptor; Sf9 cells; Covalent labelling; Aryldiazonium salt
(Weill, C. (333) 269) D-Fenfluramine; 5-HT (5-hydroxytryptamine, serotonin), Sex difference
(Datla, K.P. (333) 27)
Mustard oil
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)-tetralin)
Neurogenic inflammation; Plasma extravasation; Ear oedema; Capsaicin;
SR 140333 (Inoue, H. (333) 231) Locus coeruleus; a@,,-Adrenoceptor, ARC 239 (2-(2-(4-0-metho-
xypheny| )piperazin- | -ylJethyl}-4,4-di|m ethyl- 3(2H,4H)-isoquinolinedione ),
Na*, K *-ATPase Chlorpromazine (Ruiz-Ortega, J.A. (333) 159)
Endotoxin; Neostigmine; Neurotransmission; N°-nitro-L-arginine (Liu,
S.-H. (333) 241) Opioid
Cocaine; Lethality; Cardiovascular; Blood pressure; Seizure (Patterson,
L-Nitro-arginine methyl ester (L-NAME) A.B. (333) 47)
Angiotensin II, Enalapril; Nitric oxide (NO), Stroke (Ahmad, S. (333) 39)
Orally active
Neostigmine Bradykinin; Bradykinin receptor antagonist; FR167344; FR172357;
Endotoxin; Neurotransmission; Na*, K*-ATPase; N“°-nitro-t-arginine Bradykinin B, receptor (Inamura, N. (333) 79)
(Liu, S.-H. (333) 241)
Pacemaker cells
Smooth muscle; K* channels; Ca** stores; Charybdotoxin; Apamin
Neurogenic inflammation
Mustard oil; Plasma extravasation; Ear oedema; Capsaicin; SR 140333 (Duridanova, D.B. (333) 105)
(Inoue, H. (333) 231)
Pain
Neuropeptide Y Adenosine A, receptor; Histamine; 5-HT (5-hydroxytryp
lleum; Neuropeptide Y Y, receptor; (Rabbit) (Pheng, L.H. (333) R3) tonin) (Sawynok, J. (333) 1)
Keyword index
Papillary muscle Renovascular hypertension
Muscarinic M, receptor; Antibody; Peptide; Inotropic effect (Skomedal, Adrenomedullin; Blood pressure; Renin; Aldosterone; (Rat) (Khan, A.1.
T. (333) 169) (333) 187)
Patch clamp technique Reperfusion
Levosimendan; K* channel; K* channel, ATP-sensitive; Mesenteric Arrhythmia; Ischaemia; K* channel activator; Levcromakalim (Vegh, A.
artery, rat (Yokoshiki, H. (333) 249) (333) 33)
Peptide Scopolamine
Muscarinic M, receptor; Antibody; Inotropic effect; Papillary muscle Muscarinic M, receptor; Muscarinic M, receptor; Pirenzepine; Methoc-
(Skomedal, T. (333) 169) tramine; Alzheimer’s disease; (Delay-dependent and -independent), (%
correct choice) (Aura, J. (333) 129)
Peptide YY
Intestinal secretion; VIP (vasoactive intestinal peptide); Intestinal nerve; Seizure
a,-Adrenoceptor; a Receptor; (Rat) (Souli, A. (333) 87) Opioid; Cocaine; Lethality; Cardiovascular; Blood pressure (Patterson,
A.B. (333) 47)
PF-904
Sex difference
Airway; Airway, hyperreactivity; Eosinophil infiltration; Microvascular
leakage; Bronchus, human, isolated; Phosphodiesterase activity; Neu- D-Fenfluramine, 5-HT (S-hydroxytryptamine, serotonin); D-Norfenflura-
trophils, human; Superoxide anion generation; (Guinea pig) (Cortijo, J. mine (Datla, K.P. (333) 27)
(333) 69)
Sf9 cells
Phosphodiesterase activity Muscarinic receptor; Muscarinic receptor, m2 subtype; Covalent la-
PF-904; Airway; Airway, hyperreactivity; Eosinophil infiltration; Mi- belling; Aryldiazonium salt (Weill, C. (333) 269)
crovascular leakage; Bronchus, human, isolated; Neutrophils, human;
Smooth muscle
Superoxide anion generation; (Guinea pig) (Cortijo, J. (333) 69)
K* channels; Ca** stores; Charybdotoxin; Apamin; Pacemaker cells
(Duridanova, D.B. (333) 105)
Phosphodiesterase inhibitor
Smooth muscle, airway; Airway tone, spontaneous; Prostaglandin;
Mn?*; Ieum; Ca?* channel (Nasu, T. (333) 199)
(Guinea pig) (Thirstrup, S. (333) 215)
P-4 (1-methyl-4-piperidyl diphenylpropoxyacetate hydrochloride); Anti-
Phosphorylation
pollakiuric agent; Urinary bladder; Actomyosin ATPase activity; Calmod-
Antidepressant; Desipramine; Microtubule-associated protein 2; Micro-
ulin (Matsushima, S. (333) 93)
tubule assembly (Miyamoto, S. (333) 279)
Smooth muscle, airway
Pirenzepine
Airway tone, spontaneous; Phosphodiesterase inhibitor; Prostaglandin;
Muscarinic M, receptor; Muscarinic M, receptor; Scopolamine; Methoc-
(Guinea pig) (Thirstrup, S. (333) 215)
tramine; Alzheimer’s disease; (Delay-dependent and -independent); (%
correct choice) (Aura, J. (333) 129)
Smooth muscle contraction
Ascomycin; FK506-binding protein; Neurotransmitter release;
Plasma extravasation
Tachykininergic nerve; Iris sphincter muscle, rabbit (Kageyama, M. (333)
Mustard oil; Neurogenic inflammation; Ear oedema; Capsaicin; SR
223)
140333 (Inoue, H. (333) 231)
Sedium tauroursodeoxycho(UlRa-9t0e6 )
P-4 (1-methyl-4-piperidyl diphenylpropoxyacetate hydrochloride)
Bile duct ligation; Dehydrocholic acid; Blood coagulation factor;
Anti-pollakiuric agent; Urinary bladder; Smooth muscle; Actomyosin Cholestasis; (Rat) (Ishizaki, K. (333) 207)
ATPase activity; Calmodulin (Matsushima, S. (333) 93)
Spinal cord
P,, purinoceptor Imidazoline receptor, BU-224 (2-(4,5-dihydroimidazol-2y!)-quinoline hy-
Auricular artery; Sympathetic nerve stimulation; Purinergic transmission drochloride)); Nociception; (Rat) (Diaz, A. (333) 9)
(Haniuda, K. (333) 163)
Spinal cord, rat
Prostaglandin NMDA receptor antagonist, non-competitive; Electrophysiology; Cortex,
Smooth muscle, airway; Airway tone, spontaneous; Phosphodiesterase rat; Enantiomer (Ebert, B. (333) 99)
inhibitor; (Guinea pig) (Thirstrup, S. (333) 215)
SR 140333
Purinergic transmission Mustard oil; Neurogenic inflammation; Plasma extravasation, Ear oedema;
Auricular artery; Sympathetic nerve stimulation; P,, purinoceptor Capsaicin (Inoue, H. (333) 231)
(Haniuda, K. (333) 163)
Stroke
o Receptor Angiotensin II; Enalapril; L-nitro-arginine methy! ester (L-NAME), Nitric
Peptide YY; Intestinal secretion; VIP (vasoactive intestinal peptide); oxide (NO) (Ahmad, S. (333) 39)
Intestinal nerve; a-Adrenoceptor; (Rat) (Souli, A. (333) 87)
Superoxide anion generation
Renin PF-904; Airway; Airway, hyperreactivity; Eosinophil infiltration; Mi-
Adrenomedullin; Blood pressure; Renovascular hypertension; Aldos- crovascular leakage; Bronchus, human, isolated; Phosphodiesterase activ-
terone; (Rat) (Khan, A.I. (333) 187) ity; Neutrophils, human; (Guinea pig) (Cortijo, J. (333) 69)